Per Stirling Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$780K Buy
3,191
+90
+3% +$21K 0.09% 153
2025
Q4
$642K Buy
3,101
+182
+6% +$36K 0.07% 165
2025
Q3
$541K Buy
2,919
+9
+0.3% +$1.54K 0.06% 173
2025
Q2
$445K Buy
2,910
+2
+0.1% +$307 0.06% 179
2025
Q1
$482K Sell
2,908
-260
-8% -$40.7K 0.07% 168
2024
Q4
$458K Sell
3,168
-343
-10% -$53.2K 0.07% 175
2024
Q3
$569K Buy
3,511
+10
+0.3% +$1.59K 0.08% 163
2024
Q2
$512K Sell
3,501
-34
-1% -$5.06K 0.08% 154
2024
Q1
$559K Buy
3,535
+45
+1% +$7.16K 0.09% 132
2023
Q4
$547K Buy
3,490
+5
+0.1% +$767 0.1% 124
2023
Q3
$543K Buy
3,485
+6
+0.2% +$990 0.11% 111
2023
Q2
$576K Sell
3,479
-4
-0.1% -$646 0.12% 107
2023
Q1
$540K Sell
3,483
-200
-5% -$32.3K 0.12% 104
2022
Q4
$651K Buy
+3,683
New +$636K 0.12% 104

Other funds holding JNJ

Per Stirling Capital Management's JNJ Position: Q1 2026 in Review

Per Stirling Capital Management increased its Johnson & Johnson (JNJ) stake by 2.9% in Q1 2026, buying an estimated $21K and bringing the position to 3,191 shares worth $780K. The position accounts for 0.09% of the portfolio, ranked #153.

Per Stirling Capital Management first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Per Stirling Capital Management held 3,191 shares of Johnson & Johnson worth $780K as of Q1 2026.
  • Per Stirling Capital Management bought 90 Johnson & Johnson shares in Q1 2026, an estimated $21K.
  • Johnson & Johnson made up 0.09% of Per Stirling Capital Management's portfolio in Q1 2026, its #153 holding.
  • Per Stirling Capital Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Per Stirling Capital Management's 13F filing for Q1 2026, filed 12 May 2026.